NLRP3 and type 2 diabetes mellitus: Along these lines, advanced glycation end products (AGEs), resulting from non-enzymatic glycation of plasma proteins during hyperglycemia and thus increased in T2DM patients [171], have been shown to upregulate NLRP3 expression [172].